MODIFIED POLYPEPTIDE

PURPOSE:To provide a chemically, modified polypeptide in which antigenicity is eliminated while retaining the physiological activity of polypeptide at a high level, by subjecting amino groups in the molecule of polypeptide with a group contg. a specified polyethylene glycol residue. CONSTITUTION:Par...

Full description

Saved in:
Bibliographic Details
Main Authors TOKUNAGA KEIKO, UNUMA TSUNEO, HIROSE KATSUMI, YUKIMATSU YOSHIKAZU
Format Patent
LanguageEnglish
Published 26.11.1982
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PURPOSE:To provide a chemically, modified polypeptide in which antigenicity is eliminated while retaining the physiological activity of polypeptide at a high level, by subjecting amino groups in the molecule of polypeptide with a group contg. a specified polyethylene glycol residue. CONSTITUTION:Part or the whle of amino groups in the molecule of polypeptide such as uricase, arginase or insulin is substituted with a group of formulaI (wherein R1 is F, Cl, OH or a group which does not react with the polypeptide; the group of formula II is a polyethylene glycol residue having a number- average MW of 5,000-15,000; R2 is alkyl, an arom. group, alkylcarbonyl, arom. carbonyl, alkylaminocarbonyl, arom. amino carbonyl) to produce a modified polypeptide which is an enzyme having a physiological activity effective in the treatment of patients and in which antigenicity is lowered or completely eliminated while retaining highly the physiological activity of the polypeptide.
Bibliography:Application Number: JP19810077153